We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.92B
AUM Growth
-$382M
Cap. Flow
-$115M
Cap. Flow %
-5.98%
Top 10 Hldgs %
45.28%
Holding
275
New
41
Increased
31
Reduced
101
Closed
38

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$24.8M
2
ASTH icon
Astrana Health
ASTH
+$16.6M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$15.8M
4
LLY icon
Eli Lilly
LLY
+$15.2M
5
GPC icon
Genuine Parts
GPC
+$13M

Top Sells

Rank Stock Value
1
UWMC icon
UWM Holdings
UWMC
+$30.9M
2
WDC icon
Western Digital
WDC
+$24.7M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.6M
4
SUNC
SunocoCorp LLC
SUNC
+$11.6M
5
GXO icon
GXO Logistics
GXO
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.91%
2 Consumer Discretionary 7.8%
3 Financials 6.79%
4 Industrials 3.72%
5 Materials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLTR icon
1
PUT
Palantir
PLTR
$420B
$341M 17.78%
2,328,700
– –
LLY icon
2
PUT
Eli Lilly
LLY
$1.08T
$123M 6.43%
134,000
-20,000
-13% -$20.3M
NVDA icon
3
PUT
NVIDIA
NVDA
$5.27T
$79.5M 4.15%
456,000
– –
COF icon
4
Capital One
COF
$134B
$68.4M 3.57%
375,000
+40,000
+12% +$8.37M
CVNA icon
5
Carvana
CVNA
$79.2B
$48.7M 2.54%
775,000
+25,000
+3% +$1.86M
MDGL icon
6
PUT
Madrigal Pharmaceuticals
MDGL
$12.4B
$47.1M 2.46%
90,000
-9,000
-9% -$4.3M
ALNY icon
7
PUT
Alnylam Pharmaceuticals
ALNY
$29.6B
$42.4M 2.21%
128,100
-13,000
-9% -$4.42M
TSLA icon
8
PUT
Tesla
TSLA
$1.31T
$40.9M 2.13%
110,000
-100,000
-48% -$41.2M
PTGX icon
9
Protagonist Therapeutics
PTGX
$9.6B
$37.4M 1.95%
355,000
-25,669
-7% -$2.27M
PRAX icon
10
PUT
Praxis Precision Medicines
PRAX
$10.3B
$36.3M 1.9%
112,700
-57,100
-34% -$17.7M
WVE icon
11
Wave Life Sciences
WVE
$993M
$35.5M 1.85%
4,900,000
+885,000
+22% +$11.5M
BDX icon
12
Becton Dickinson
BDX
$49.4B
$35.4M 1.85%
225,000
+135,000
+150% +$24.8M
KSPI icon
13
Kaspi.kz JSC
KSPI
$18.1B
$35.2M 1.84%
475,000
+210,000
+79% +$15.8M
ANAB icon
14
AnaptysBio
ANAB
$1.71B
$34.7M 1.81%
625,000
-23,093
-4% -$1.24M
HGV icon
15
Hilton Grand Vacations
HGV
$3.34B
$30.3M 1.58%
775,000
+30,000
+4% +$1.34M
GXO icon
16
GXO Logistics
GXO
$5.37B
$25.9M 1.35%
500,000
-185,000
-27% -$10.6M
MOH icon
17
Molina Healthcare
MOH
$10.2B
$21.3M 1.11%
160,000
+25,000
+19% +$3.98M
AMLX icon
18
Amylyx Pharmaceuticals
AMLX
$2.63B
$21.3M 1.11%
1,530,000
-120,000
-7% -$1.69M
MGTX icon
19
MeiraGTx Holdings
MGTX
$1.21B
$21.2M 1.11%
2,450,000
-109,082
-4% -$829K
PHAT icon
20
Phathom Pharmaceuticals
PHAT
$688M
$20.6M 1.07%
1,850,000
+65,000
+4% +$821K
QURE icon
21
CALL
uniQure
QURE
$3.12B
$20.5M 1.07%
1,253,600
+503,500
+67% +$10.2M
AMTM
22
Amentum Holdings
AMTM
$5.48B
$20.2M 1.05%
775,000
-60,000
-7% -$1.88M
IAG icon
23
IAMGOLD
IAG
$10.4B
$19.8M 1.03%
1,050,000
+150,000
+17% +$2.97M
TGTX icon
24
TG Therapeutics
TGTX
$7.64B
$19.6M 1.02%
590,000
+230,000
+64% +$6.85M
ASTH icon
25
Astrana Health
ASTH
$1.71B
$17.2M 0.9%
+700,000
New +$16.6M
1
2 3 4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM

683 Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, 683 Capital Management held 275 positions worth $1.92B, down 17% from $2.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

683 Capital Management withdrew a net $115M in Q1 2026, closing 38 positions and reducing 101 holdings. Its most notable exit was UWM Holdings, an estimated $30.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Astrana Health worth $17.2M.

  • 683 Capital Management's largest Q1 2026 buy was Astrana Health: 700,000 shares worth $17.2M.
  • 683 Capital Management added most to Becton Dickinson in Q1 2026, an estimated $24.8M increase.
  • 683 Capital Management's biggest Q1 2026 reduction was GXO Logistics, cutting an estimated $10.6M.
  • 683 Capital Management fully exited UWM Holdings in Q1 2026, selling an estimated $30.9M.
  • 683 Capital Management's ten largest holdings make up 45% of its $1.92B portfolio in Q1 2026.
  • 683 Capital Management opened 41 new positions and closed 38 in Q1 2026.
  • 683 Capital Management's portfolio value fell 17% quarter-over-quarter to $1.92B.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.